These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15636503)

  • 21. Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex.
    Epstein RA
    Yale J Health Policy Law Ethics; 2005; 5(2):741-70. PubMed ID: 16052898
    [No Abstract]   [Full Text] [Related]  

  • 22. America's drug problem.
    Philpott S
    Hastings Cent Rep; 2012; 42(4):9-10. PubMed ID: 22777971
    [No Abstract]   [Full Text] [Related]  

  • 23. Another popular painkiller gets the government's hook.
    Querna E
    US News World Rep; 2005 Apr; 138(14):47. PubMed ID: 15839129
    [No Abstract]   [Full Text] [Related]  

  • 24. The Food and Drug Administration and its problems.
    Iglehart JK
    N Engl J Med; 1991 Jul; 325(3):217-20. PubMed ID: 2052069
    [No Abstract]   [Full Text] [Related]  

  • 25. ASHP congressional testimony on the "gray market" in pharmaceuticals.
    Am J Hosp Pharm; 1986 Feb; 43(2):426-9. PubMed ID: 3953608
    [No Abstract]   [Full Text] [Related]  

  • 26. [The Brazilian pharmaceutical market and the North American war effort].
    Quintaneiro T
    Estud Hist; 2002; (29):141-64. PubMed ID: 18030707
    [No Abstract]   [Full Text] [Related]  

  • 27. Is it a cosmetic, a drug, or both? (Or is it soap?).
    Center for Safety and Applied Nutrition/Office of Cosmetics and Colors US Food and Drug Administration
    Plast Surg Nurs; 2008; 28(4):195-7. PubMed ID: 19092587
    [No Abstract]   [Full Text] [Related]  

  • 28. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 29. Your health in the 21st century. A better safety net.
    Rosenberg D
    Newsweek; 2005; 145(26A):70-2. PubMed ID: 16375152
    [No Abstract]   [Full Text] [Related]  

  • 30. A new era in drug regulation?
    Dresser R
    Hastings Cent Rep; 2005; 35(3):10-1. PubMed ID: 16092391
    [No Abstract]   [Full Text] [Related]  

  • 31. Research, regulation and development of new pharmaceuticals: past, present and future. II.
    Lasagna L
    Am J Med Sci; 1972 Feb; 263(2):66-78. PubMed ID: 5017858
    [No Abstract]   [Full Text] [Related]  

  • 32. The Pain Relief Promotion Act: Congress's misguided intervention into end-of-life care.
    Buzzee SE
    Univ Cincinnati Law Rev; 2001; 70(1):217-49. PubMed ID: 16389683
    [No Abstract]   [Full Text] [Related]  

  • 33. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of follow-on biologics.
    Frank RG
    N Engl J Med; 2007 Aug; 357(9):841-3. PubMed ID: 17761588
    [No Abstract]   [Full Text] [Related]  

  • 35. Should the FDA regulate nicotine-containing cigarettes? Has the Agency established a legal basis and, if not, should congress grant it?
    Carchman SH
    Food Drug Law J; 1996; 51(1):85-138. PubMed ID: 11794355
    [No Abstract]   [Full Text] [Related]  

  • 36. Relative efficacy. When the government decides what drugs should be prescribed, is the patient better served?
    Ohio State Med J; 1972 Aug; 68(8):748-52 passim. PubMed ID: 5077306
    [No Abstract]   [Full Text] [Related]  

  • 37. Acetaminophen toxicity: changing perceptions on a social/medical issue.
    Lee WM
    Hepatology; 2007 Oct; 46(4):966-70. PubMed ID: 17894320
    [No Abstract]   [Full Text] [Related]  

  • 38. AHP's awful losing streak.
    Whitford D
    Fortune; 1999 Nov; 140(10):52, 56. PubMed ID: 10662389
    [No Abstract]   [Full Text] [Related]  

  • 39. What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the Food and Drug Administration.
    Ehrenpreis ED; Kulkarni P; Burke C;
    Am J Gastroenterol; 2013 May; 108(5):642-6. PubMed ID: 23644956
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-diversion turf war: will Cardinal ruling reinvent roles, DEA strategy?
    Lee J
    Mod Healthc; 2012 Mar; 42(10):8-9. PubMed ID: 22458066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.